Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
Back to Search Results

Connection

Search Results to Jennifer Michelle Trujillo

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Trujillo, Jennifer

Item TypeName
Academic Article Association of pancreatitis with glucagon-like peptide-1 agonist use.
Concept Receptors, Glucagon
Concept Glucagon
Concept Glucagon-Like Peptides
Concept Glucagon-Like Peptide 1
Academic Article GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
Academic Article Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.
Academic Article Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.
Academic Article Liraglutide: A New Option for the Treatment of Obesity.
Academic Article Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes.
Academic Article iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes.
Academic Article Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin.
Academic Article Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes.
Concept Glucagon-Like Peptide-1 Receptor
Academic Article Oral semaglutide in type 2 diabetes.
Academic Article Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies.
Academic Article Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.
Academic Article Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes.
Academic Article Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.
Academic Article Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes.

Search Criteria
  • Glucagon

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)